SMTI (STOCKS)
Sanara MedTech Inc. Common Stock
$17.600000
+1.070000 (+6.47%)
Prev close: $16.530000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Seth Yon
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $161.43M
- Employees
- 141
- P/E (TTM)
- -4.04
- P/B (TTM)
- 24.90
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.09 | $0.11 | -0.0222 | -19.79% |
|
Sep 2025 (Q3)
|
$0.09 | $-0.22 | +0.3093 | +141.04% |
|
Jun 2025 (Q2)
|
$-0.23 | $-0.45 | +0.2188 | +48.75% |
|
Mar 2025 (Q1)
|
$-0.41 | $-0.52 | +0.1031 | +20.02% |
Financial Statements
| Revenues | $103.12M |
| Benefits Costs and Expenses | $103.51M |
| Cost Of Revenue | $7.52M |
| Costs And Expenses | $103.51M |
| Gross Profit | $95.60M |
| Operating Expenses | $88.29M |
| Selling, General, and Administrative Expenses | $78.72M |
| Depreciation and Amortization | $2.66M |
| Research and Development | $5.07M |
| Other Operating Expenses | $1.84M |
| Operating Income/Loss | $7.30M |
| Income/Loss Before Equity Method Investments | -$393.12K |
| Income/Loss From Continuing Operations After Tax | -$393.12K |
| Income/Loss From Continuing Operations Before Tax | -$393.12K |
| Income/Loss From Discontinued Operations Net Of Tax | -$37.17M |
| Income/Loss From Equity Method Investments | -$952.47K |
| Interest Expense, Operating | $6.76M |
| Net Income/Loss | -$37.57M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$5.44K |
| Net Income/Loss Attributable To Parent | -$37.56M |
| Net Income/Loss Available To Common Stockholders, Basic | -$37.56M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.36 |
| Diluted Earnings Per Share | -$4.36 |
| Basic Average Shares | 8,623,028 |
| Diluted Average Shares | 8,623,028 |
| Assets | $72.94M |
| Current Assets | $33.54M |
| Inventory | $3.95M |
| Other Current Assets | $29.59M |
| Noncurrent Assets | $39.40M |
| Fixed Assets | $456.96K |
| Intangible Assets | $18.64M |
| Other Non-current Assets | $20.30M |
| Liabilities | $67.01M |
| Current Liabilities | $18.63M |
| Noncurrent Liabilities | $48.39M |
| Long-term Debt | $45.97M |
| Other Non-current Liabilities | $2.42M |
| Equity | $5.93M |
| Equity Attributable To Noncontrolling Interest | -$8.67K |
| Equity Attributable To Parent | $5.94M |
| Liabilities And Equity | $72.94M |
| Net Cash Flow From Operating Activities | $6.79M |
| Net Cash Flow From Operating Activities, Continuing | $6.79M |
| Net Cash Flow From Investing Activities | -$14.97M |
| Net Cash Flow From Investing Activities, Continuing | -$14.97M |
| Net Cash Flow From Financing Activities | $8.89M |
| Net Cash Flow From Financing Activities, Continuing | $8.89M |
| Net Cash Flow | $700.56K |
| Net Cash Flow, Continuing | $700.56K |
| Comprehensive Income/Loss | -$37.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$37.57M |
| Other Comprehensive Income/Loss | $0.00 |